Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke?

Stroke. 2002 Jun;33(6):1723-6. doi: 10.1161/01.str.0000016922.22707.27.

Author

Graeme J Hankey¹

Affiliation

¹ Department of Neurology, Royal Perth Hospital, Perth, Western Australia. gjhankey@cyllene.uwa.edu.au

PMID: 12053018
DOI: 10.1161/01.str.0000016922.22707.27

No abstract available

Publication types

Comparative Study

MeSH terms

Anticoagulants / therapeutic use
Aspirin / therapeutic use*
Brain Ischemia / etiology
Brain Ischemia / prevention & control*
Data Interpretation, Statistical
Embolism / complications
Endpoint Determination
Humans
Odds Ratio
Platelet Aggregation Inhibitors / therapeutic use
Randomized Controlled Trials as Topic / methods
Randomized Controlled Trials as Topic / standards
Randomized Controlled Trials as Topic / statistics & numerical data
Research Design / standards
Secondary Prevention
Sensitivity and Specificity
Stroke / etiology
Stroke / prevention & control*
Treatment Outcome
Warfarin / therapeutic use*

Substances

Anticoagulants
Platelet Aggregation Inhibitors
Warfarin
Aspirin